| 10500114
|
Structure-assisted design of mechanism-based irreversible inhibitors of human rhinovirus 3C protease with potent antiviral activity against multiple rhinovirus serotypes. |
Proc Natl Acad Sci U S A |
1999 |
Matthews DA;Dragovich PS;Webber SE;Fuhrman SA;Patick AK;Zalman LS;Hendrickson TF;Love RA;Prins TJ;Marakovits JT;Zhou R;Tikhe J;Ford CE;Meador JW;Ferre RA;Brown EL;Binford SL;Brothers MA;DeLisle DM;Worland ST |
View
More |
| 11159387
|
Molecular dynamics simulations of human rhinovirus and an antiviral compound. |
Biophys J |
2001 |
Speelman B;Brooks BR;Post CB |
View
More |
| 11302940
|
Liquid chromatography-mass spectrometry and liquid chromatography-NMR characterization of in vitro metabolites of a potent and irreversible peptidomimetic inhibitor of rhinovirus 3C protease. |
Drug Metab Dispos |
2001 |
Zhang KE;Hee B;Lee CA;Liang B;Potts BC |
View
More |
| 12515488
|
Virus-ligand interactions: identification and characterization of ligand binding by NMR spectroscopy. |
J Am Chem Soc |
2003 |
Benie AJ;Moser R;Bauml E;Blaas D;Peters T |
View
More |
| 12746549
|
Coronavirus main proteinase (3CLpro) structure: basis for design of anti-SARS drugs. |
Science |
2003 |
Anand K;Ziebuhr J;Wadhwani P;Mesters JR;Hilgenfeld R |
View
More |
| 21795339
|
Enterovirus 71 and coxsackievirus A16 3C proteases: binding to rupintrivir and their substrates and anti-hand, foot, and mouth disease virus drug design. |
J Virol |
2011 |
Lu G;Qi J;Chen Z;Xu X;Gao F;Lin D;Qian W;Liu H;Jiang H;Yan J;Gao GF |
View
More |
| 21835784
|
Structural basis for antiviral inhibition of the main protease, 3C, from human enterovirus 93. |
J Virol |
2011 |
Costenaro L;Kaczmarska Z;Arnan C;Janowski R;Coutard B;Sola M;Gorbalenya AE;Norder H;Canard B;Coll M |
View
More |
| 23549610
|
The newly emerged SARS-like coronavirus HCoV-EMC also has an "Achilles\' heel": current effective inhibitor targeting a 3C-like protease. |
Protein Cell |
2013 |
Ren Z;Yan L;Zhang N;Guo Y;Yang C;Lou Z;Rao Z |
View
More |
| 25792507
|
Peptidomimetic ethyl propenoate covalent inhibitors of the enterovirus 71 3C protease: a P2-P4 study. |
J Enzyme Inhib Med Chem |
2016 |
Ang MJ;Lau QY;Ng FM;Then SW;Poulsen A;Cheong YK;Ngoh ZX;Tan YW;Peng J;Keller TH;Hill J;Chu JJ;Chia CS |
View
More |
| 34506130
|
Pan-3C Protease Inhibitor Rupintrivir Binds SARS-CoV-2 Main Protease in a Unique Binding Mode. |
Biochemistry |
2021 |
Lockbaum GJ;Henes M;Lee JM;Timm J;Nalivaika EA;Thompson PR;Kurt Yilmaz N;Schiffer CA |
View
More |
| 34960671
|
RIPK1 Is Cleaved by 3C Protease of Rhinovirus A and B Strains and Minor and Major Groups. |
Viruses |
2021 |
Croft SN;Walker EJ;Ghildyal R |
View
More |
| 7500332
|
A novel basis of capsid stabilization by antiviral compounds. |
J Mol Biol |
1995 |
Phelps DK;Post CB |
View
More |
| 7629816
|
[(Biaryloxy)alkyl]isoxazoles: picornavirus inhibitors. |
J Med Chem |
1995 |
Guiles JW;Diana GD;Pevear DC |
View
More |
| 7731021
|
Picornavirus inhibitors: trifluoromethyl substitution provides a global protective effect against hepatic metabolism. |
J Med Chem |
1995 |
Diana GD;Rudewicz P;Pevear DC;Nitz TJ;Aldous SC;Aldous DJ;Robinson DT;Draper T;Dutko FJ;Aldi C;et al. |
View
More |
| 8057290
|
Oxadiazoles as ester bioisosteric replacements in compounds related to disoxaril. Antirhinovirus activity. |
J Med Chem |
1994 |
Diana GD;Volkots DL;Nitz TJ;Bailey TR;Long MA;Vescio N;Aldous S;Pevear DC;Dutko FJ |
View
More |
| 8939746
|
Human rhinovirus 3 at 3.0 A resolution. |
Structure |
1996 |
Zhao R;Pevear DC;Kremer MJ;Giranda VL;Kofron JA;Kuhn RJ;Rossmann MG |
View
More |
| 9122218
|
The pentamer channel stiffening model for drug action on human rhinovirus HRV-1A. |
Proc Natl Acad Sci U S A |
1997 |
Vaidehi N;Goddard WA 3rd |
View
More |
| 9512706
|
Influence of an antiviral compound on the temperature dependence of viral protein flexibility and packing: a molecular dynamics study. |
J Mol Biol |
1998 |
Phelps DK;Rossky PJ;Post CB |
View
More |
